Recherche
-
Assessment Of Early Changes In Spectral Domain-Optical Coherence Tomography After Initiation Of Treatment With Intravitreal Aflibercept (Eylea) Over A 12-Week Period For Patients With Neovascular Age-Related Macular Degeneration: A Multicenter French Study (Start)
(RETINA. vol. 41, n° 3, pp. 588-594, 2021-03-01)Article de revue -
Management of retinal pigment epithelium tear during anti-VEGF therapy
(RETINA. vol. Publish Ahead of Print, 2020-12-16)Article de revue -
Response to letter: COVID-19 and macular edema-a necessary blindness?
(Graefe's Archive for Clinical and Experimental Ophthalmology. vol. 258, n° 11, pp. 2571, 2020)Article de revue -
Evaluation à long terme de l'efficacité de la toxine botulique dans l'esotropie précoce
(Journal Français D'Ophtalmologie. vol. 44, n° 4, pp. 509-518, 2021-04)Article de revue -
Avis d'experts : actualisation des bonnes pratiques des injections intravitreennes. Recommandations de la Societe francaise d'ophtalmologie et de la Societe francaise d'hygiene hospitaliere
(Journal Français D'Ophtalmologie. vol. 43, n° 1, pp. 59-62, 2020)Article de revue -
Predicting the retinal content in omega-3 fatty acids for age-related macular-degeneration
(Clinical and Translational Medicine. vol. 11, n° 7, pp. e404, 2021-07)Article de revueLibre accès -
Standardization of optical coherence tomography angiography nomenclature in retinal vascular diseases: first survey results
(Ophthalmology Retina, 2020-12-31)Article de revueLibre accès -
Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update
(Graefe's Archive for Clinical and Experimental Ophthalmology, 2021-01-07)Article de revueLibre accès -
Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems
(BMC Ophthalmology. vol. 20, n° 1, pp. 294, 2020)Article de revueLibre accès -
TENAYA and LUCERNE: Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration
(Ophthalmology Science. vol. 1, n° 4, 2021-12)Article de revueLibre accès